Answers are grounded in this paper and cite their sources.
Anakinra was well tolerated as a single 50-mg or 150-mg intraarticular injection in patients with OA of the knee. However, anakinra was not associated with improvements in OA symptoms compared with placebo.
No takes yet. Share an insight, caveat, or question.
Chevalier et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: